Recent KRBP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2024 08:30:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/27/2024 09:21:01 PM
- Kiromic BioPharma Provides Updates on its Deltacel-01 Clinical Trial • Business Wire • 06/20/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 10:32:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:30:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:36:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:36:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:30:17 PM
- Kiromic BioPharma Reports Six-Month Results from First Patient Enrolled in Deltacel-01 Clinical Trial • Business Wire • 06/06/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 09:13:41 PM
- Kiromic BioPharma Reports Favorable Results at Six Weeks from Fourth Patient in Deltacel-01 Clinical Trial • Business Wire • 05/29/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 09:03:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 09:00:22 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 05/20/2024 09:00:06 PM
- Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site • Business Wire • 05/20/2024 12:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/17/2024 08:43:17 PM
- Kiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three Patients • Business Wire • 04/24/2024 12:08:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/19/2024 08:30:26 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 04/10/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/05/2024 08:30:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2024 08:30:20 PM
- Kiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical Trial • Business Wire • 04/02/2024 12:18:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 03/21/2024 09:21:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2024 09:58:13 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM